Abstract
In the past decade, considerable advances have occurred in our understanding of the pathophysiology of this disorder, its metabolic sequelae, and its management, particularly with respect to continuous low-dose insulin infusion and the potential benefits of phosphate. This article reviews these advances as they pertain to children.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Bicarbonates / therapeutic use
-
Brain Edema / etiology
-
Child
-
Child, Preschool
-
Diabetic Ketoacidosis / complications
-
Diabetic Ketoacidosis / physiopathology*
-
Diabetic Ketoacidosis / therapy
-
Epinephrine / metabolism
-
Fluid Therapy
-
Glucagon / metabolism
-
Growth Hormone / metabolism
-
Humans
-
Hydrocortisone / metabolism
-
Insulin / metabolism
-
Insulin / therapeutic use
-
Insulin Secretion
-
Ketone Bodies / metabolism
-
Phosphates / therapeutic use
-
Water-Electrolyte Balance
Substances
-
Bicarbonates
-
Insulin
-
Ketone Bodies
-
Phosphates
-
Growth Hormone
-
Glucagon
-
Hydrocortisone
-
Epinephrine